Amlodipine And Valsartan
Product Images NDC 40032-082

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 40032-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novel Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fe621d98-figure-01 (Fe621d98 Figure 01)

Two adjacent line graphs displaying the probability of achieving target blood pressure levels at Week 8 for Amlodipine and Valsartan compared to Valsartan alone, Amlodipine alone, and placebo. The left graph shows probabilities for systolic blood pressure below 140 mmHg, while the right graph shows probabilities for diastolic blood pressure below 90 mmHg, each plotted against baseline blood pressure values.*

FDA Label Image

Fe621d98-figure-02 (Fe621d98 Figure 02)

Two graphs depicting the probability of achieving target blood pressure levels at week 8. The left graph shows the probability of systolic blood pressure falling below 130 mmHg, while the right graph shows diastolic blood pressure below 80 mmHg. Both graphs compare results for Amlodipine and Valsartan tablets 10 mg/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, with baseline systolic and diastolic blood pressure on the x-axes.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-strctre.jpg (Fe621d98 Figure 03)

Chemical structure diagram showing molecular components, including a chlorophenyl group and other functional groups consistent with the formulation of Amlodipine and Valsartan. The image depicts the two active ingredients' chemical structures as represented in the product.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-val-strctre.jpg (Fe621d98 Figure 04)

Chemical structure diagram of the active ingredient in Amlodipine and Valsartan, showing molecular bonds and groups consistent with the valsartan molecule. The structure includes labeled chemical groups and stereochemistry.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-5-160-30.jpg (Fe621d98 Figure 05)

Label for Amlodipine and Valsartan tablets by Novel Laboratories, Inc. Lists active ingredients: 5 mg amlodipine besylate (equivalent) and 160 mg valsartan per tablet. The label includes storage instructions, dosage referral, quantities (30 tablets), and manufacturer information from Somerset, NJ, with a barcode and lot/expiration fields.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-5-160-90.jpg (Fe621d98 Figure 06)

Label for Amlodipine and Valsartan tablets, containing 5 mg of amlodipine and 160 mg of valsartan per tablet. The label shows the product is manufactured by Novel Laboratories, Inc. It indicates a package size of 90 tablets and includes storage instructions and dosage information for reference.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-10-160-30.jpg (Fe621d98 Figure 07)

Amlodipine and Valsartan Tablets 10 mg/160 mg label from Novel Laboratories, Inc. The label lists the active ingredients per tablet: 13.9 mg amlodipine besylate (equivalent to 10 mg amlodipine) and 160 mg valsartan. It includes dosage usage instructions referencing the package insert, storage conditions, package count of 30 tablets, prescription only designation, and manufacturer details.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-10-160-90.jpg (Fe621d98 Figure 08)

Label for Amlodipine and Valsartan tablets by Novel Laboratories, Inc. The label shows the strength as 10 mg/160 mg and indicates a package size of 90 tablets. It includes active ingredient amounts per tablet and storage instructions, with manufacturer details and a barcode on the right side.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-5-320-30.jpg (Fe621d98 Figure 09)

Amlodipine and Valsartan tablets label from Novel Laboratories, Inc. The tablets contain 5 mg of amlodipine (as 6.9 mg amlodipine besylate) and 320 mg of valsartan. The package contains 30 tablets, indicated for prescription use only. Storage instructions specify 20° to 25°C with allowed excursions. The label includes dosage notes, manufacturer information, and a barcode.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-5-320-90.jpg (Fe621d98 Figure 10)

Label for Amlodipine and Valsartan tablets, 5 mg/320 mg, manufactured by Novel Laboratories, Inc. The label indicates a package size of 90 tablets and includes dosage information as well as storage instructions. It also features the Novel Laboratories logo and an NDC barcode.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-10-320-30.jpg (Fe621d98 Figure 11)

Label for Amlodipine and Valsartan tablets, strength 10 mg/320 mg, by Novel Laboratories, Inc. The label shows NDC 40032-080-03, specifies 30 tablets per package, and provides active ingredient amounts: 13.9 mg amlodipine besylate (equivalent to 10 mg amlodipine) and 320 mg valsartan. It includes storage instructions, manufacturer information, and a barcode.*

FDA Label Image

C:\users\ldeepthi\desktop\amlo-valsrtn\amlo-10-320-90.jpg (Fe621d98 Figure 12)

A label for Amlodipine and Valsartan Tablets, 10 mg/320 mg strength, from Novel Laboratories, Inc. The label indicates a package size of 90 tablets and includes storage instructions to store at 20° to 25°C with permitted excursions. The label also displays the NDC 40032-080-09 and notes the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.